These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 22509073)

  • 21. Pancreatic cancer stem cells: new understanding of tumorigenesis, clinical implications.
    Ischenko I; Seeliger H; Kleespies A; Angele MK; Eichhorn ME; Jauch KW; Bruns CJ
    Langenbecks Arch Surg; 2010 Jan; 395(1):1-10. PubMed ID: 19421768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarkers and pathways of chemoresistance and chemosensitivity for personalized treatment of pancreatic adenocarcinoma.
    Zemanek T; Melichar B; Lovecek M; Soucek P; Mohelnikova-Duchonova B
    Pharmacogenomics; 2019 Jan; 20(2):113-127. PubMed ID: 30539680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, Synthesis and Biological Evaluation of novel Hedgehog Inhibitors for treating Pancreatic Cancer.
    Kumar V; Chaudhary AK; Dong Y; Zhong HA; Mondal G; Lin F; Kumar V; Mahato RI
    Sci Rep; 2017 May; 7(1):1665. PubMed ID: 28490735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic cancer stem cells: new insight into a stubborn disease.
    Zhan HX; Xu JW; Wu D; Zhang TP; Hu SY
    Cancer Lett; 2015 Feb; 357(2):429-37. PubMed ID: 25499079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of human equilibrative nucleoside transporter1 in pancreatic cancer receiving gemcitabin-based chemotherapy: a meta-analysis.
    Liu ZQ; Han YC; Zhang X; Chu L; Fang JM; Zhao HX; Chen YJ; Xu Q
    PLoS One; 2014; 9(1):e87103. PubMed ID: 24475233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-gene signaling pathways in pancreatic cancer.
    Drakaki A; Iliopoulos D
    Biomed J; 2013; 36(5):200-8. PubMed ID: 24225187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stem cell-based targeted therapy in pancreatic cancer: Current approaches and future prospects.
    Mahadiuzzaman ASM; Dain Md Opo FA; Alkarim S
    Tissue Cell; 2024 Aug; 89():102449. PubMed ID: 38924893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells.
    Bao B; Wang Z; Ali S; Ahmad A; Azmi AS; Sarkar SH; Banerjee S; Kong D; Li Y; Thakur S; Sarkar FH
    Cancer Prev Res (Phila); 2012 Mar; 5(3):355-64. PubMed ID: 22086681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of phosphatidylinositol 3-kinase signaling pathways in pancreatic cancer.
    Sun C; Rosendahl AH; Andersson R; Wu D; Wang X
    Pancreatology; 2011; 11(2):252-60. PubMed ID: 21625196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-10a promotes epithelial-to-mesenchymal transition and stemness maintenance of pancreatic cancer stem cells via upregulating the Hippo signaling pathway through WWC2 inhibition.
    Wang C; Yin W; Liu H
    J Cell Biochem; 2020 Nov; 121(11):4505-4521. PubMed ID: 32542845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pancreatic cancer--mechanisms of chemoresistance].
    Borowa-Mazgaj B
    Postepy Hig Med Dosw (Online); 2016 Mar; 70():169-79. PubMed ID: 26943314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current and future biomarkers for pancreatic adenocarcinoma.
    Loosen SH; Neumann UP; Trautwein C; Roderburg C; Luedde T
    Tumour Biol; 2017 Jun; 39(6):1010428317692231. PubMed ID: 28618958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-VEGF treatment-resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotype.
    Carbone C; Moccia T; Zhu C; Paradiso G; Budillon A; Chiao PJ; Abbruzzese JL; Melisi D
    Clin Cancer Res; 2011 Sep; 17(17):5822-32. PubMed ID: 21737511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
    Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
    Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted therapies in pancreatic cancer: Promises and failures.
    Barati Bagherabad M; Afzaljavan F; ShahidSales S; Hassanian SM; Avan A
    J Cell Biochem; 2019 Mar; 120(3):2726-2741. PubMed ID: 28703890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
    Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
    Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic cancer: understanding and overcoming chemoresistance.
    Wang Z; Li Y; Ahmad A; Banerjee S; Azmi AS; Kong D; Sarkar FH
    Nat Rev Gastroenterol Hepatol; 2011 Jan; 8(1):27-33. PubMed ID: 21102532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SNAIL2 contributes to tumorigenicity and chemotherapy resistance in pancreatic cancer by regulating IGFBP2.
    Masuo K; Chen R; Yogo A; Sugiyama A; Fukuda A; Masui T; Uemoto S; Seno H; Takaishi S
    Cancer Sci; 2021 Dec; 112(12):4987-4999. PubMed ID: 34628696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retinoic Acid Reduces Stem Cell-Like Features in Pancreatic Cancer Cells.
    Herreros-Villanueva M; Er TK; Bujanda L
    Pancreas; 2015 Aug; 44(6):918-24. PubMed ID: 26035122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
    Mittal V
    Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.